Brimonidine and timolol ophthalmic and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Brimonidine and timolol ophthalmic and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine / timolol ophthalmic
Brand name: Combigan
Synonyms: Brimonidine and Timolol
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine and timolol ophthalmic-Insulin glargine, recombinant Subcutaneous
- Brimonidine and timolol ophthalmic-Insulin glulisine
- Brimonidine and timolol ophthalmic-Insulin Glulisine (Cartridges and Pens)
- Brimonidine and timolol ophthalmic-Insulin Glulisine (Vials)
- Brimonidine and timolol ophthalmic-Insulin glulisine Subcutaneous
- Brimonidine and timolol ophthalmic-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine ophthalmic
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine Tartrate eent
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine Tartrate topical
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine topical
- Insulin glargine and lixisenatide Subcutaneous-Brimonidine Topical application
- Insulin glargine and lixisenatide Subcutaneous-Brintellix